Holuka Eugene Myron - Insider Non-Derivative Transactions at Citius Pharmaceuticals, Inc. (CTXR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 13, 2024, Holuka Eugene Myron's relationship to Citius Pharmaceuticals, Inc. (CTXR) is Director, and currently has 2,415 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTXR insiders.
Data Source: SEC.
Holuka Eugene Myron - Insider Non-Derivative Transactions at CTXR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 14, 2024 | F -- (Common Stock) | 48 | 0.75 | 2367 |
| Mar 14, 2024 | M -- (Common Stock) | 2415 | 0.02 | 2415 |